Thyrocare enters pregnancy testing segment, ropes in Yami Gautam as brand ambassador
NiveshIQ
NSE: THYROCARE · Healthcare
Thyrocare Technologies Ltd.
₹477.50▲ ₹21.20 (+4.65%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on THYROCARE. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Thyrocare Technologies Ltd.
Thyrocare Technologies Limited, headquartered in Navi Mumbai, operates in the diagnostic testing and imaging services space, with a third segment selling glucometers and strips under the Sugarscan brand. The company’s core revenue drivers are its Diagnostic Testing Services, which include consumables for sample collection and pathology promotion, and its Imaging Services, which supply radio-pharmaceuticals and reporting consumables. In Q2 FY27, Thyrocare reported revenue of ₹270.8 cr, up 25.1% YoY, while net income fell 68% to ₹15 cr due to a ₹45 cr impairment charge. Despite the earnings dip, the company’s total FY27 revenue reached ₹876 cr and net income ₹176 cr, reflecting a robust top-line growth trajectory. Thyrocare’s competitive position is strengthened by its extensive network of l
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹571.88 Cr +8.58% | ₹687.35 Cr +20.19% | ₹829.04 Cr +20.61% |
| EBITDA Margin | 24.03% | 27.69% | 31.61% |
| Net Profit | ₹70.76 Cr +9.72% | ₹91.51 Cr +29.32% | ₹163.05 Cr +78.18% |
| EPS | ₹13.42 | ₹17.13 | ₹10.27 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Thyrocare enters pregnancy testing segment, ropes in Yami Gautam as brand ambassador
Thyrocare reports 25% revenue growth in Q2 FY27 earnings call
🔒
+ 3 more stories about Thyrocare Technologies Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹271 Cr, PAT ₹16 Cr, EPS ₹0.96, EBITDA margin 33.0%. Growth context: revenue YoY +25.1%, PAT YoY -66.9%, revenue QoQ +12.8%, PAT QoQ -69.6%.
Test volumes, test mix, B2B/reference-lab traction, pricing discipline, and operating leverage remain the key forward dr...
FY26 (last completed FY): revenue ₹829 Cr, PAT ₹163 Cr, EBITDA margin 31.6%, EPS ₹10.27. Year-on-year: revenue YoY +20.6...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Strides Pharma Science Ltd.Sun Pharma Advanced Research Company Ltd.Sun Pharmaceutical Industries Ltd.Supriya Lifescience Ltd.Suven Life Sciences Ltd.Syngene International Ltd.Torrent Pharmaceuticals Ltd.Ventive Hospitality Ltd.Vijaya Diagnostic Centre Ltd.Viyash Scientific Ltd.Wockhardt Ltd.Yatharth Hospital & Trauma Care Services Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for THYROCARE
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track THYROCARE alongside your other holdings
Unlock full THYROCARE research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Thyrocare Technologies Ltd.?
NiveshIQ detects active intelligence signals for Thyrocare Technologies Ltd. (THYROCARE) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Thyrocare Technologies Ltd.?
Thyrocare Technologies Ltd. operates in the Healthcare sector with a market capitalisation of ₹773,525.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.